Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

1.43

Margin Of Safety %

-5

Put/Call OI Ratio

0.83

EPS Next Q Diff

0.04

EPS Last/This Y

0.52

EPS This/Next Y

0.43

Price

93.84

Target Price

127.52

Analyst Recom

1.19

Performance Q

-13.18

Relative Volume

1.53

Beta

0.67

Ticker: BSX




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-10BSX100.920.730.84193212
2025-11-11BSX102.50.740.76198874
2025-11-12BSX104.130.730.43201185
2025-11-13BSX105.020.720.39204911
2025-11-14BSX102.690.710.36206153
2025-11-17BSX101.750.712.03203156
2025-11-18BSX99.220.721.74204652
2025-11-19BSX96.990.720.69205041
2025-11-20BSX96.610.721.91205141
2025-11-21BSX96.870.690.34202601
2025-11-24BSX98.040.800.85150498
2025-11-25BSX101.380.811.44161424
2025-11-26BSX100.960.830.69163582
2025-12-01BSX101.070.825.30162620
2025-12-02BSX99.010.891.18169548
2025-12-03BSX98.570.901.13170239
2025-12-04BSX97.710.910.76176404
2025-12-05BSX97.490.910.33177561
2025-12-08BSX93.840.831.56170387
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-10BSX100.9111.52763.43.03
2025-11-11BSX102.5011.52803.93.03
2025-11-12BSX104.1111.52803.73.03
2025-11-13BSX105.0211.52800.83.03
2025-11-14BSX102.6911.52620.53.03
2025-11-17BSX101.7811.52697.33.03
2025-11-18BSX99.2211.52601.83.03
2025-11-19BSX97.0111.52617.83.03
2025-11-20BSX96.6111.52725.33.03
2025-11-21BSX96.8811.52767.13.03
2025-11-24BSX98.0611.52822.03.03
2025-11-25BSX101.3611.52950.53.03
2025-11-26BSX100.9611.52726.63.03
2025-12-01BSX101.0211.52717.33.03
2025-12-02BSX99.0211.52633.13.03
2025-12-03BSX98.5711.52723.03.03
2025-12-04BSX97.7311.52699.53.03
2025-12-05BSX97.5211.52737.93.03
2025-12-08BSX93.8411.5- 3.03
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-10BSX-7.840.131.33
2025-11-11BSX-7.670.131.33
2025-11-12BSX-7.670.131.32
2025-11-13BSX-7.840.131.32
2025-11-14BSX-7.840.131.32
2025-11-17BSX-7.840.461.32
2025-11-18BSX-7.840.461.32
2025-11-19BSX-7.840.461.32
2025-11-20BSX-7.840.461.32
2025-11-21BSX-7.840.461.32
2025-11-24BSX-8.130.591.32
2025-11-25BSX-8.130.591.32
2025-11-26BSX-8.130.591.43
2025-12-01BSX-8.260.511.43
2025-12-02BSX-8.520.511.43
2025-12-03BSX-8.520.511.43
2025-12-04BSX-6.070.511.43
2025-12-05BSX-5.200.511.43
2025-12-08BSX-5.200.571.43
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.75

Avg. EPS Est. Current Quarter

0.78

Avg. EPS Est. Next Quarter

0.79

Insider Transactions

-5.2

Institutional Transactions

0.57

Beta

0.67

Average Sales Estimate Current Quarter

5277

Average Sales Estimate Next Quarter

5197

Fair Value

88.75

Quality Score

89

Growth Score

98

Sentiment Score

13

Actual DrawDown %

14.3

Max Drawdown 5-Year %

-25.2

Target Price

127.52

P/E

50.19

Forward P/E

27.04

PEG

3.11

P/S

7.19

P/B

5.95

P/Free Cash Flow

36.38

EPS

1.87

Average EPS Est. Cur. Y​

3.03

EPS Next Y. (Est.)

3.47

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14.43

Relative Volume

1.53

Return on Equity vs Sector %

-14.9

Return on Equity vs Industry %

-5.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.05

EBIT Estimation

Boston Scientific Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 53000
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
stock quote shares BSX – Boston Scientific Corporation Stock Price stock today
news today BSX – Boston Scientific Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BSX – Boston Scientific Corporation yahoo finance google finance
stock history BSX – Boston Scientific Corporation invest stock market
stock prices BSX premarket after hours
ticker BSX fair value insiders trading